Loading...

Rising US Healthcare Cost Controls Will Squeeze Orthobiologics Margins

Published
24 Aug 25
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
35.9%
7D
-0.2%

Author's Valuation

SEK 128.5% undervalued intrinsic discount

AnalystLowTarget Fair Value